G-CSF (granulocyte colony-stimulating factor) is a protein your body naturally produces to stimulate the bone marrow to make neutrophils, the white blood cells that serve as your immune system’s first responders against bacterial and fungal infections. A synthetic version of this protein is widely used as a medication, most commonly to protect people undergoing chemotherapy from dangerous drops in their white blood cell counts. It’s one of the most prescribed supportive therapies in cancer treatment.
How G-CSF Works in the Body
Your bone marrow constantly produces neutrophils and releases them into the bloodstream, where they patrol for invaders. G-CSF accelerates this process in two ways: it tells the bone marrow to produce more neutrophils, and it triggers the release of both mature and immature neutrophils into circulation. Interestingly, this mobilization appears to happen indirectly. Rather than acting on neutrophils themselves, G-CSF sends signals that change the bone marrow environment, reducing the chemical signals that normally keep neutrophils anchored in place.
The effect is fast and selective. In animal studies, a single injection of G-CSF produces a five-fold increase in circulating neutrophils, beginning within 30 minutes and peaking around 12 hours. Only neutrophils respond to this signal. Lymphocytes and eosinophils (other types of white blood cells) are not affected.
Why G-CSF Is Prescribed
The most common reason people receive G-CSF is chemotherapy-induced neutropenia. Chemotherapy drugs kill rapidly dividing cells, which includes cancer cells but also the precursor cells in bone marrow that make neutrophils. This leaves patients vulnerable to infections that a healthy immune system would easily handle. G-CSF pushes the bone marrow to replenish neutrophils faster, shortening the window of vulnerability.
G-CSF also plays a critical role in stem cell transplants. Before a transplant, it’s given to either the patient or a healthy donor to flood the bone marrow with signals that push stem cells out into the bloodstream, where they can be collected through a process similar to blood donation. After transplant, G-CSF helps the new bone marrow engraft and begin producing white blood cells.
Some people need G-CSF for reasons unrelated to cancer. Certain genetic conditions cause severe, chronic neutropenia from birth. Others develop low neutrophil counts without any identifiable cause. In these cases, G-CSF can be used on an ongoing basis to maintain a functional immune defense.
Short-Acting vs. Long-Acting Forms
G-CSF medications come in two main forms. The short-acting version (filgrastim) requires daily injections, typically starting one to three days after chemotherapy and continuing until neutrophil counts recover. The long-acting version (pegfilgrastim) is a modified form of the same molecule, designed to stay in the body longer. It requires only a single injection per chemotherapy cycle, given at least 24 hours after chemo.
The timing matters. Giving G-CSF too close to chemotherapy can backfire. Because G-CSF stimulates bone marrow cells to multiply, administering it on the same day as chemo could cause those newly activated cells to be killed by the chemo drugs still circulating in the body, potentially worsening neutropenia rather than preventing it.
What Treatment Looks Like
G-CSF is given as a subcutaneous injection, meaning it goes into the fatty tissue just under the skin rather than into a vein. Many people learn to give themselves the injections at home using prefilled syringes. Recommended injection sites include the front of the upper arms, the abdomen (at least two inches from the belly button), and the front or outer thighs. Rotating between different sites with each injection helps reduce soreness and prevents scar tissue from building up.
Your care team monitors your response through blood tests that measure your absolute neutrophil count (ANC). Treatment typically continues until that count recovers above a specific threshold, usually confirmed on two consecutive days. If you’re receiving G-CSF to prevent infection after chemo, the target is generally a count above 1.0 × 10⁹/L. In more urgent situations, like active infection with severely depleted neutrophils, treatment may begin when the count drops below 0.1 × 10⁹/L and continue until it climbs above 0.5 × 10⁹/L.
Common Side Effects
Bone pain is the side effect people notice most. It typically shows up in the lower back, pelvis, or sternum, which makes sense because those are the areas where the most active bone marrow is located. The pain reflects the bone marrow working overtime to produce neutrophils. Reported rates vary, with clinical studies finding it affects roughly 1 to 10 percent of patients. For most people, over-the-counter pain relief is enough to manage it.
Other common side effects include fatigue, headaches, and mild soreness or redness at the injection site. These tend to be temporary and resolve once treatment stops.
Rare but Serious Risks
Serious complications from G-CSF are uncommon but worth knowing about. The most concerning is splenic rupture. G-CSF can cause the spleen to enlarge as it works harder to process the surge of white blood cells, and in rare cases, the spleen can tear. The warning sign to watch for is sudden, sharp pain in the upper left side of the abdomen, sometimes radiating to the left shoulder. This has been reported in both cancer patients and healthy stem cell donors. Life-threatening events like stroke and heart attack have also been documented in rare cases, though a direct causal link is difficult to establish given that many G-CSF recipients are already medically complex.
If you experience sudden or severe abdominal pain, shoulder pain, or feel faint while receiving G-CSF, these symptoms warrant immediate medical attention.
G-CSF for Stem Cell Donors
Healthy people who volunteer to donate stem cells for someone else’s transplant also receive G-CSF, typically at a dose of 10 micrograms per kilogram of body weight daily for four to six days. This drives stem cells out of the bone marrow and into the bloodstream, where they’re collected through a procedure called leukapheresis. Research comparing standard and higher doses of G-CSF for this purpose has found no significant benefit to using more, meaning the standard dose mobilizes stem cells just as effectively without unnecessary additional exposure.
For donors, the experience involves several days of injections followed by a collection session that can last a few hours. Side effects mirror those of patients: bone pain, fatigue, and headaches that resolve after the process is complete.